| For: | Jin T, Nakatani H, Taguchi T, Nakano T, Okabayashi T, Sugimoto T, Kobayashi M, Araki K. STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 2006; 12(5): 703-708 [PMID: 16521182 DOI: 10.3748/wjg.v12.i5.703] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/703.htm |
| Number | Citing Articles |
| 1 |
Ying Huang, Fan Li, Weidong Tong, Anping Zhang, Yujun He, Tao Fu, Baohua Liu. Hydrogen Sulfide, a Gaseous Transmitter, Stimulates Proliferation of Interstitial Cells of Cajal via Phosphorylation of AKT Protein Kinase. The Tohoku Journal of Experimental Medicine 2010; 221(2) doi: 10.1620/tjem.221.125
|
| 2 |
Panagiotis Tsagozis, Jordi Gonzalez-Molina, Anna-Maria Georgoudaki, Kaisa Lehti, Joseph Carlson, Andreas Lundqvist, Felix Haglund, Monika Ehnman. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1296 doi: 10.1007/978-3-030-59038-3_20
|
| 3 |
Yvonne M.H. Versleijen-Jonkers, Myrella Vlenterie, Addy C.M. van de Luijtgaarden, Winette T.A. van der Graaf. Anti-angiogenic therapy, a new player in the field of sarcoma treatment. Critical Reviews in Oncology/Hematology 2014; 91(2) doi: 10.1016/j.critrevonc.2014.02.001
|
| 4 |
F. Berger, E.C. Winkler, C. Ruderer, M.F. Reiser. Moderne bildgebende Diagnostik bei Weichteilsarkomen. Der Chirurg 2009; 80(3) doi: 10.1007/s00104-008-1594-7
|
| 5 |
Siyue Du, Nicole Wagner, Kay-Dietrich Wagner. The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis. PPAR Research 2020; 2020 doi: 10.1155/2020/3608315
|
| 6 |
Alex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko. VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opinion on Investigational Drugs 2007; 16(1) doi: 10.1517/13543784.16.1.83
|
| 7 |
Sergei Boichuk, Pavel Dunaev, Aigul Galembikova, Elena Valeeva. Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance. Cancers 2024; 16(17) doi: 10.3390/cancers16173103
|
| 8 |
Alexander S. Kiselyov, Marina Semenova, Victor V. Semenov. 3,4-Disubstituted isothiazoles: Novel potent inhibitors of VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 2009; 19(4) doi: 10.1016/j.bmcl.2008.12.078
|
| 9 |
N. Schramm, E. Englhart, M. Schlemmer, M. Hittinger, C. Übleis, C.R. Becker, M.F. Reiser, F. Berger. Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: Comparison of RECIST, Choi and volumetric criteria. European Journal of Radiology 2013; 82(6) doi: 10.1016/j.ejrad.2013.02.034
|
| 10 |
Alexander S. Kiselyov, Marina Semenova, Victor V. Semenov. (1,2,3-Triazol-4-yl)benzenamines: Synthesis and activity against VEGF receptors 1 and 2. Bioorganic & Medicinal Chemistry Letters 2009; 19(5) doi: 10.1016/j.bmcl.2009.01.046
|
| 11 |
Sridurga Mithraprabhu, Kate L Loveland. Control of KIT signalling in male germ cells: what can we learn from other systems?. Reproduction 2009; 138(5) doi: 10.1530/REP-08-0537
|
| 12 |
Ichiro Sekine, Chun Yang Wen, Shinji Naito, Ayumi Yoshizaki, Yuka Mine, Yang Cheul Cho, Toshiyuki Nakayama. Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas. World Journal of Gastroenterology 2006; 12(38): 6182-6187 doi: 10.3748/wjg.v12.i38.6182
|
| 13 |
F. Berger, M. Reiser. Neue bildgebende Strategien zum Monitoring molekularer Pharmakotherapien bei GIST. Der Radiologe 2008; 48(9) doi: 10.1007/s00117-008-1740-8
|
| 14 |
Mona-Elisabeth Revheim, Knut Håkon Hole, Øyvind Sverre Bruland, Edmund Reitan, Bodil Bjerkehagen, Lars Julsrud, Therese Seierstad. Multimodal functional imaging for early response assessment in GIST patients treated with imatinib. Acta Oncologica 2014; 53(1) doi: 10.3109/0284186X.2013.798428
|
| 15 |
John C. McAuliffe, Alexander J.F. Lazar, Dan Yang, Dejka M. Steinert, Wei Qiao, Peter F. Thall, A. Kevin Raymond, Robert S. Benjamin, Jonathan C. Trent. Association of Intratumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate. Clinical Cancer Research 2007; 13(22) doi: 10.1158/1078-0432.CCR-07-0895
|
| 16 |
Rosario S. Rivera, Hitoshi Nagatsuka, Mehmet Gunduz, Beyhan Cengiz, Esra Gunduz, Chong Huat Siar, Hidetsugu Tsujigiwa, Ryo Tamamura, Kok Ng Han, Noriyuki Nagai. C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma. Virchows Archiv 2008; 452(1) doi: 10.1007/s00428-007-0524-2
|
| 17 |
T. B. Wang, W. S. Qiu, B. Wei, M. H. Deng, H. B. Wei, W. G. Dong. Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. Irish Journal of Medical Science 2009; 178(3) doi: 10.1007/s11845-009-0315-7
|
| 18 |
Ylva. A. Weeda, Gijsbert M. Kalisvaart, Floris H. P. van Velden, Hans Gelderblom, Aart. J. van der Molen, Judith V. M. G. Bovee, Jos A. van der Hage, Willem Grootjans, Lioe-Fee de Geus-Oei. Early Prediction and Monitoring of Treatment Response in Gastrointestinal Stromal Tumors by Means of Imaging: A Systematic Review. Diagnostics 2022; 12(11) doi: 10.3390/diagnostics12112722
|
| 19 |
Feng Pan, Jie Den, Chunfang Zhang, He Wang, Jin Cheng, Weizhen Wu, Nan Hong, Yi Wang, Gayle E. Woloschak. The Therapeutic Response of Gastrointestinal Stromal Tumors to Imatinib Treatment Assessed by Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging with Histopathological Correlation. PLOS ONE 2016; 11(12) doi: 10.1371/journal.pone.0167720
|
| 20 |
Tianyuan Bian, Shitao Gao, Xinyu Sun, Songtao Zhou, Yufeng Pei, Jie Song. Single-Molecule Detection on Intrastrand Interactions among G4 Clusters. Analytical Chemistry 2025; 97(22) doi: 10.1021/acs.analchem.5c00884
|
| 21 |
Marcus Schlemmer, Steven P. Sourbron, Nicole Schinwald, Konstantin Nikolaou, Christoph R. Becker, Maximilian F. Reiser, Frank Berger. Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy. European Journal of Radiology 2011; 77(2) doi: 10.1016/j.ejrad.2009.07.031
|
| 22 |
Masakazu Imamura, Hidetaka Yamamoto, Norimoto Nakamura, Yoshinao Oda, Takashi Yao, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara, Masazumi Tsuneyoshi. Prognostic significance of angiogenesis in gastrointestinal stromal tumor. Modern Pathology 2007; 20(5) doi: 10.1038/modpathol.3800767
|
| 23 |
Hajime Nakatani, Toyokazu Akimori, Yuka Takezaki, Kazuhiro Hanazaki. Vascular endothelial growth factors and their receptors in the novel human cell line, HN-Eso-1, established from esophageal spindle cell carcinoma. The Journal of Medical Investigation 2010; 57(3,4) doi: 10.2152/jmi.57.232
|
| 24 |
Bilge Can, Filiz Karagoz, Levent Yildiz, Arzu Yildirim, Mehmet Kefeli, Guzin Gonullu, Bedri Kandemir. Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors. APMIS 2012; 120(9) doi: 10.1111/j.1600-0463.2012.02887.x
|
| 25 |
Tian-bao Wang, Xiu-qing Wei, Wei-hao Lin, Han-ping Shi, Wen-guang Dong. The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft. Clinical and Experimental Medicine 2012; 12(2) doi: 10.1007/s10238-011-0143-8
|